CN101928259B - 2-芳基噻唑衍生物及其药物组合物 - Google Patents
2-芳基噻唑衍生物及其药物组合物 Download PDFInfo
- Publication number
- CN101928259B CN101928259B CN200910033852A CN200910033852A CN101928259B CN 101928259 B CN101928259 B CN 101928259B CN 200910033852 A CN200910033852 A CN 200910033852A CN 200910033852 A CN200910033852 A CN 200910033852A CN 101928259 B CN101928259 B CN 101928259B
- Authority
- CN
- China
- Prior art keywords
- represent
- branched
- chch
- acid
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200910033852A CN101928259B (zh) | 2009-06-18 | 2009-06-18 | 2-芳基噻唑衍生物及其药物组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200910033852A CN101928259B (zh) | 2009-06-18 | 2009-06-18 | 2-芳基噻唑衍生物及其药物组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101928259A CN101928259A (zh) | 2010-12-29 |
CN101928259B true CN101928259B (zh) | 2012-10-03 |
Family
ID=43367740
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200910033852A Active CN101928259B (zh) | 2009-06-18 | 2009-06-18 | 2-芳基噻唑衍生物及其药物组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101928259B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103936693B (zh) * | 2013-01-22 | 2016-06-15 | 沈阳药科大学 | 2-(3-氰基-4-取代苯基)-4-甲基-1,3-硒唑-5-甲酸及其酯类化合物和制备方法 |
CN109810073B (zh) * | 2019-02-28 | 2023-01-06 | 南京海辰药业股份有限公司 | 4-芳基噻唑衍生物及其药物组合物 |
CN113024534B (zh) * | 2019-12-24 | 2023-03-21 | 武汉光谷亚太医药研究院有限公司 | 2-吡啶基噻唑衍生物及其应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0513379A1 (en) * | 1990-11-30 | 1992-11-19 | Teijin Limited | 2-arylthiazole derivative and pharmaceutical composition containing the same |
WO2004020420A1 (en) * | 2002-08-30 | 2004-03-11 | F.Hoffmann-La Roche Ag | Novel 2-arylthiazole compounds as pparalpha and ppargama agonists |
WO2007070433A2 (en) * | 2005-12-12 | 2007-06-21 | Merck & Co., Inc. | 2-arylthiazole derivatives as cxcr3 receptor modulators |
-
2009
- 2009-06-18 CN CN200910033852A patent/CN101928259B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0513379A1 (en) * | 1990-11-30 | 1992-11-19 | Teijin Limited | 2-arylthiazole derivative and pharmaceutical composition containing the same |
WO2004020420A1 (en) * | 2002-08-30 | 2004-03-11 | F.Hoffmann-La Roche Ag | Novel 2-arylthiazole compounds as pparalpha and ppargama agonists |
WO2007070433A2 (en) * | 2005-12-12 | 2007-06-21 | Merck & Co., Inc. | 2-arylthiazole derivatives as cxcr3 receptor modulators |
Also Published As
Publication number | Publication date |
---|---|
CN101928259A (zh) | 2010-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI675026B (zh) | 稠環衍生物、其製備方法、中間體、藥物組合物及應用 | |
EP3875458A1 (en) | Diphenyl-like compound, intermediate thereof, preparation method therefor, pharmaceutical composition thereof and uses thereof | |
JP6469092B2 (ja) | イミダゾリジンジオン化合物及び薬物組成物 | |
JP5933746B2 (ja) | イミダゾリジンジオン系化合物およびその用途 | |
CN108524482B (zh) | 2-(取代苯氨基)苯甲酸类fto抑制剂治疗白血病的用途 | |
JP6635527B2 (ja) | 高尿酸血症又は痛風の治療又は予防用化合物 | |
AU2016218693B2 (en) | Substituted amino six-membered saturated heterocyclic fat used as long-acting DPP-IV inhibitor | |
CN101137660A (zh) | 作为抗糖尿病化合物的苯并噻唑、噻唑并吡啶、苯并噁唑和噁唑并吡啶衍生物 | |
EP3287463A1 (en) | Condensed-ring pyrimidylamino derivative, preparation method therefor, and intermediate, pharmaceutical composition and applications thereof | |
CN107445896B (zh) | 一种具有抗肿瘤活性的苯基异羟肟酸类化合物及其应用 | |
CN107286156A (zh) | 新型urat1抑制剂及其在医药上的应用 | |
CN103333134B (zh) | 2-(3-氰基-4-烷氧基)苯基-4-取代噻唑-5-甲酸类化合物、组合物及其制备方法和用途 | |
CN101928259B (zh) | 2-芳基噻唑衍生物及其药物组合物 | |
WO2015089137A1 (en) | Acylguanidines as tryptophan hydroxylase inhibitors | |
KR102420892B1 (ko) | 요산 배출을 촉진시키는 urat1 억제제 | |
CN107151236A (zh) | 一种2,3-环氧丁二酰衍生物及其制备方法和用途 | |
CN106478619A (zh) | 一类黄嘌呤氧化酶抑制剂及其应用 | |
JP6199406B2 (ja) | ジアシルグリセロールアシルトランスフェラーゼ阻害剤としての新規化合物 | |
CN107759588B (zh) | 一类苯基-(吡唑并[1,5-a]吡啶-3-基)甲酮衍生物 | |
CN109810073B (zh) | 4-芳基噻唑衍生物及其药物组合物 | |
CN112430221B (zh) | 用于预防、治疗或减轻高尿酸血症或痛风的化合物及其应用 | |
EP4163287A1 (en) | A class of aryl glucoside derivatives, preparation method therefor and application thereof | |
JP2023511222A (ja) | 置換ピリダジノン類化合物とその用途 | |
CN113563319A (zh) | 具有磷酸二酯酶4b抑制活性的吲唑杂环类化合物 | |
CN107556316A (zh) | 含桥环的咪唑衍生物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CI01 | Correction of invention patent gazette |
Correction item: Description Correct: complete False: Content missing Number: 52 Volume: 26 |
|
CI02 | Correction of invention patent application |
Correction item: Description Correct: The instructions are complete False: The content of the instructions is missing Number: 52 Page: Description Volume: 26 |
|
ERR | Gazette correction |
Free format text: CORRECT: DESCRIPTION; FROM: CONTENT ABSENT TO: CONTENT COMPLETE |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: NANJING HICIN PHARMACEUTICAL CO., LTD. Free format text: FORMER NAME: HAICHEN PHARMACEUTICAL CO., LTD., NANJING |
|
CP01 | Change in the name or title of a patent holder |
Address after: 210046 Jiangsu province Nanjing HENGFA Nanjing economic and Technological Development Zone, Road No. 1 Patentee after: Nanjing hicin pharmaceutical Limited by Share Ltd Address before: 210046 Jiangsu province Nanjing HENGFA Nanjing economic and Technological Development Zone, Road No. 1 Patentee before: Haichen Pharmaceutical Co., Ltd., Nanjing |